Prof. Dr. Jörn Schattenberg

Pic of Prof. Dr. Jörn Schattenberg

Director Department of Medicine Internal Medicine II, Saarland University, Medical Center and Saarland University Faculty of Medicine

Role in LiSyM-Cancer

  • Partner in SMART-NAFLD
  • Prospective collection of tissue samples and medical imaging
  • Access to serum samples from patients with MASLD

Expertise

  • Development of new diagnostic and therapeutic approaches for liver diseases
  • Development of new concepts for the early detection, prevention and treatment of metabolic liver diseases
  • Metabolic-dysfunction associated steatotic liver disease (MASLD) and alcoholic liver disease (ALD)

Degrees

  • 2023 Full Professor (Saarland University)
  • 2019 Associate Professor of Internal Medicine (APL; University Medical Center Mainz)
  • 2013 Assistant Professor (Venia legendi, Internal Medicine)
  • 2002 Medical License (MD) and Medical degree (Promotion; Dr. med.)

Professional Experience

  • Since 2023 Director Department of Internal Medicine II, Saarland University Medical Center Homburg (Germany)
  • 2021-2023 Co-Deputy Director, I. Department of Medicine, University Medical Center Mainz (Germany)
  • 2017-2023 Head of Hepatology outpatient and clinical trial unit, I. Department of Medicine, Mainz (Germany)
  • Since 2013 Head of translational Hepatology (research laboratory and clinical trials)
  • 2011 Board Certification, Gastroenterology and Hepatology (Germany)
  • 2010 Board Certification, Internal Medicine (Germany)

Honors and Awards (selection)

  • 2014 Walter-Krienitz-Gedenkpreis der DGVS; Arbeit zu Magenkarzinomen
  • 2012 Annual price German Association for the Study of Liver Disease (GASL) der YAEL-Stiftung
  • 2008 Annual price Gastroenterologischen Arbeitsgesellschaft Rheinland-Pfalz Saarland (GARPS)